Table 1.
Drug | Liver Contraindications | Risk Level of DILI | DILI Pattern |
---|---|---|---|
systemic corticosteroids | Generic caution in liver failure | + | hepatocellular or mixed |
tocilizumab | ALT > 5 times URL | ++ | hepatocellular |
sarilumab | ALT > 1.5 times URL | ++ | hepatocellular |
anakinra | Not recommended in severe liver failure (Child-Pugh C) | + | hepatocellular |
baricitinib, tofacitinib, imatinib | Not recommended in severe liver failure (Child-Pugh C) | + | hepatocellular |
remdesivir | ALT > 5 times URL | ++ | hepatocellular |
low-molecular-weight heparins | Generic caution in liver failure | + | hepatocellular |
NSAIDs | Contraindicated in severe liver failure (Child-Pugh C), caution in mild or moderate liver failure (indication to use low dosage) | ++ | hepatocellular |
paracetamol | Contraindicated in severe liver failure (Child-Pugh C), caution in mild or moderate liver failure (indication to use low dosage) | ++++ | hepatocellular |
antibiotics amoxicillin-clavulanate trimethoprim/sulfamethoxazole azitromicin |
+++ ++ ++ |
cholestatic cholestatic mixed |